CID 9632931

N-(2-oxo-2-(2-(3-phenoxybenzylidene)hydrazino)ethyl)tetradecanamide

Structural Information

Molecular Formula
C29H41N3O3
SMILES
CCCCCCCCCCCCCC(=O)NCC(=O)N/N=C/C1=CC(=CC=C1)OC2=CC=CC=C2
InChI
InChI=1S/C29H41N3O3/c1-2-3-4-5-6-7-8-9-10-11-15-21-28(33)30-24-29(34)32-31-23-25-17-16-20-27(22-25)35-26-18-13-12-14-19-26/h12-14,16-20,22-23H,2-11,15,21,24H2,1H3,(H,30,33)(H,32,34)/b31-23+
InChIKey
SKROOXZYWYCHCN-UQRQXUALSA-N
Compound name
N-[2-oxo-2-[(2E)-2-[(3-phenoxyphenyl)methylidene]hydrazinyl]ethyl]tetradecanamide
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

0
Patents

479.3148 Da
Monoisotopic Mass

8.3
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 480.32208 226.5
[M+Na]+ 502.30402 234.2
[M+NH4]+ 497.34862 230.4
[M+K]+ 518.27796 225.0
[M-H]- 478.30752 230.5
[M+Na-2H]- 500.28947 231.1
[M]+ 479.31425 228.3
[M]- 479.31535 228.3
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

No patent data available for this compound.